Article
Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening
2021-12-25
Abstract excerpt
Experiments with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are limited by the need for biosafety level 3 (BSL3) conditions. A SARS-CoV-2 replicon system rather than an in vitro infection system is suitable for antiviral screening since it can be handled under BSL2 conditions and does not produce infectious particles. However, the reported replicon systems are cumbersome because of the need for...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 94eb8575-124a-55e3-afe3-e370c7247864
- DOI
- 10.1101/2021.12.23.474055
